{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:25:41Z","timestamp":1788297941501,"version":"build-2803163510"},"reference-count":109,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and aims<\/jats:title><jats:p>Medication\u2010assisted treatment (<jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content>) is a key component in overdose prevention, reducing illicit opiate use and risk of blood\u2010borne virus infection. By retaining participants in <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> programs for longer periods of time, more noticeable and permanent changes in drug use, risk behavior and quality of life can be achieved. Many studies have documented retention in <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> programs in high\u2010income countries, using a 50% average 12\u2010month follow\u2010up retention rate as a marker for a successful <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> program. This study contributes to a systematic understanding of how successful programs have been in retaining participants in low\u2010 and middle\u2010income countries (<jats:styled-content style=\"fixed-case\">LMIC<\/jats:styled-content>) over time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>referred <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>eporting <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>tems for <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>ystematic <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>eviews and <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eta\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>nalyses (<jats:styled-content style=\"fixed-case\">PRISMA<\/jats:styled-content>) guidelines, we conducted a systematic literature search to identify <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> program studies that documented changes in retention over time for participants in buprenorphine and methadone programs in <jats:styled-content style=\"fixed-case\">LMIC<\/jats:styled-content>. Retention was measured for participants by length of follow\u2010up, type of <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> and treatment dosage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 58 <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> program studies, with 27\u2009047 participants eligible for inclusion in the review. Overall average retention after 12 months was 54.3% [95% confidence interval (<jats:styled-content style=\"fixed-case\">CI)<\/jats:styled-content>\u2009=\u200946.2, 63.7%]. Overall average retention was moderately good for both buprenorphine (48.3%, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\u2009=\u200922.1, 74.6%) and methadone (56.6%, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\u2009=\u200945.9%, 67.3%) after 12 months of treatment. Among programs using methadone there was no statistically significant difference in average retention by dosage level, and the 10 highest and lowest dosage programs obtained similar average retention levels after 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Medication\u2010assisted treatment programs in low\u2010 and middle\u2010income countries achieve an average 50% retention rate after 12 months, with wide variation across programs but little difference between those using buprenorphine versus methadone.<\/jats:p><\/jats:sec>","DOI":"10.1111\/add.12303","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T10:42:15Z","timestamp":1374057735000},"page":"20-32","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Retention of participants in medication\u2010assisted programs in low\u2010 and middle\u2010income countries: an international systematic review"],"prefix":"10.1111","volume":"109","author":[{"given":"Jonathan","family":"Feelemyer","sequence":"first","affiliation":[{"name":"The Baron Edmond de Rothschild Chemical Dependency Institute Beth Israel Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Des Jarlais","sequence":"additional","affiliation":[{"name":"The Baron Edmond de Rothschild Chemical Dependency Institute Beth Israel Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Arasteh","sequence":"additional","affiliation":[{"name":"The Baron Edmond de Rothschild Chemical Dependency Institute Beth Israel Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu S.","family":"Abdul\u2010Quader","sequence":"additional","affiliation":[{"name":"Global AIDS Program Centers for Disease Control and Prevention  Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Hagan","sequence":"additional","affiliation":[{"name":"College of Nursing New York University  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).World Drug Report. Vienna: United Nations;2012."},{"key":"e_1_2_6_3_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).World Drug Report 2006 Vol. 1. Analysis. Vienna: United Nations;2006."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90064-W"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/10884609309149701"},{"key":"e_1_2_6_6_1","unstructured":"HarwoodH. J. NapolitanoD. M. KristiansenP. L. CollinsJ. J.Economic costs to society of alcohol and drug abuse and mental illness: 1980. Rockville MD: Research Triangle Institute;1984."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.83.8.1144"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(02)00047-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20014"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.02.007"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05356-2"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2010.531672"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.01.010"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11090"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004145.pub3"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02249.x"},{"key":"e_1_2_6_17_1","unstructured":"GersteinD. R. JohnsonR. A. HarwoodH. J. FountainD. SuterN. MalloyK.Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment (CALDATA); General Report. Chicago IL: National Opinion Research Center (NORC) University of Chicago;1994."},{"key":"e_1_2_6_18_1","volume-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"Ward J.","year":"1997"},{"key":"e_1_2_6_19_1","first-page":"48","article-title":"A methadone maintenance program in a community general hospital: a first year's experience","volume":"22","author":"Goldman F. R.","year":"1973","journal-title":"MD State Med J"},{"key":"e_1_2_6_20_1","first-page":"802","article-title":"Analysis of applications received by the New York City Methadone Maintenance Treatment Program during its first two years of operation","volume":"1","author":"Newman R. G.","year":"1973","journal-title":"Proc Natl Conf Methadone Treat"},{"key":"e_1_2_6_21_1","first-page":"170","article-title":"HIV prevention among injecting drug users: responses in developing and transitional countries","volume":"113","author":"Ball A. L.","year":"1998","journal-title":"Public Health Rep"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00963.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-5-23"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.09.002"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e32832a1dc0"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.12.011"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph6020787"},{"key":"e_1_2_6_28_1","first-page":"50","article-title":"Unpacking drug detoxification in Nepal: in\u2010depth interviews with participants to identify reasons for success and failure","volume":"16","author":"Kant C. K.","year":"2012","journal-title":"Int J Psychosoc Rehabil"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq210"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2012.06.009"},{"key":"e_1_2_6_31_1","unstructured":"NissaramaneshB. TraceM. RobertsM.The rise of harm reduction in the Islamic Republic of Iran. Oxford UK: The Beckley Foundation Drug Policy Programme;2005."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.04.006"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.006"},{"key":"e_1_2_6_34_1","unstructured":"World Bank.Country and Lending Groups by Income\u2014World Bank Country and Lending Groups. Washington DC: World Bank;2011."},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-7-24"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2006.05.022"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/095952304100017044163"},{"key":"e_1_2_6_38_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins J. P. T.","year":"2011"},{"key":"e_1_2_6_39_1","volume-title":"Stata 12","author":"Stata Corporation","year":"2012"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-7-29"},{"key":"e_1_2_6_41_1","unstructured":"DvoriakS. DumchevK. TrophimchenkoI. AlticeF.Opioid agonists maintenance therapy decreases HIV\u2010seroconversion among injecting drug users in Ukraine.Proceedings of the XIX International AIDS Conference Washington DC 25 July2012."},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(10)70874-9"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2008.09.004"},{"key":"e_1_2_6_44_1","unstructured":"ShabadalH. AlluinL. LuhmannN. MaguetO. QuetierM. WisseE.Induction methadone dosages way beyond international recommendations in the Islamic Republic of Afghanistan. Paper presented at the XIX International AIDS Conference Washington DC 25 July2012."},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e318156cc19"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018982"},{"key":"e_1_2_6_47_1","unstructured":"YadavD. AmbekarA. AgrawalA. DhawanA. DhingraN. MehraJ.et\u2009al.A pilot project of providing opioid substitution treatment (OST) with buprenorphine for injecting drug users (IDUs) though collaboration between government hospitals and NGOs: factors influencing compliance to treatment.Proceedings of the XIX International AIDS Conference Washington DC 25 July2012."},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00222-2"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00132576-200205000-00005"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(01)00202-2"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(03)00024-2"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01218.x"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00272-6"},{"key":"e_1_2_6_54_1","first-page":"23","article-title":"Treatment of intravenous buprenorphine dependence: a randomized open clinical trial","volume":"6","author":"Ahmadi J.","year":"2003","journal-title":"Ger J Psychiatry"},{"key":"e_1_2_6_55_1","unstructured":"Diah Setia UtamiA. A. Nyoman HanatiI. MardiatiR. Riza SarasvitaD. R.Interim results of pilot study on methadone maintenance program in Indonesia.Proceedings of the XVI International Harm Reduction Conference London UK 2005."},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1057\/jphp.2011.10"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(98)00057-7"},{"key":"e_1_2_6_58_1","unstructured":"DuoL.Methadone clinic clients HIV incidence in Yunnan China.Proceedings of the VI International AIDS Society on HIV Pathogenesis Treatment and Prevention Conference Geneva Switzerland 2011."},{"key":"e_1_2_6_59_1","unstructured":"DvoriakS.Opioid substitution therapy (OST) with buprenorphine in Ukraine\u2014way to prevent HIV\/AIDS among IDUs.Proceedings of the XVII International AIDS Society Conference Geneva Switzerland 2008."},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.91014"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.3923\/ijp.2012.445.449"},{"key":"e_1_2_6_62_1","unstructured":"LambdinB. MbwamboJ. BruceD. MasaoF. NyandindiC. IvoY.et\u2009al.Evaluating enrollment and retention of people who inject drugs in the medication assisted treatment cascade in Dar es Salaam Tanzania.Proceedings of the XIX International AIDS Conference Washington DC 26 July2012."},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2012.679840"},{"key":"e_1_2_6_64_1","unstructured":"MokriA. Taheri\u2010NakhostH.Efficacy of methadone maintenance treatment in preventing illicit drug use and HIV related high\u2010risk behavior in Iranian drug abusers.Proceedings of the XX International Harm Reduction Conference London UK 2004."},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2281"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/1010539511404396"},{"key":"e_1_2_6_67_1","unstructured":"NgmansunR.Harm reduction strategies in the Indian Ocean Region\u2014the Mauritian experience.Proceedings of the XVIII International AIDS Conference Washington DC 2010."},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.07.009"},{"key":"e_1_2_6_69_1","unstructured":"SarasvitaR.Predictors of patient retention in methadone maintenance program in Jakarta Indonesia. in: NIDA International Drug Abuse Research;2005."},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9963-y"},{"key":"e_1_2_6_71_1","unstructured":"CaoX. WuK. PangR. L.Predictors of dropping out of methadone maintenance treatment in China: a six\u2010year cohort study.Proceedings of the XIX International AIDS Conference Washington DC 26 July2012."},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03859.x"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-7-30"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60954-X"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410.pub3"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-81"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.06.013"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.11.009"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.12.014"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61311-2"},{"key":"e_1_2_6_81_1","unstructured":"World Health Organization (WHO).WHO Collaborative Study on Substitution Therapy of Opioid Dependence and HIV\/AIDS. Geneva: WHO Department of Mental Health and Substance Dependence;2003."},{"key":"e_1_2_6_82_1","unstructured":"UchtenhagenA. RehmJ.WHO Guidelines for Psychosocially Assisted Pharmacological Treatment of Persons Dependent on Opioids.WHO Guidelines for Pyschosocially Assisted Pharmacotherapy of Opioid Dependence. Geneva: WHO Press;2007."},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.02.005"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2006.00431.x"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802491563"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1086\/630209"},{"key":"e_1_2_6_87_1","first-page":"145","article-title":"Childhood abuse and neglect and loss of self\u2010regulation","volume":"58","author":"Van der Kolk B. A.","year":"1994","journal-title":"Bull Menninger Clin"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.11.008"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1159\/000217586"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.10.005"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.09.024"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00157.x"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.09.004"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.11.010"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e318259b2c4"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2010.534124"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03490.x"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.03.009"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.12.007"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04020.x"},{"key":"e_1_2_6_101_1","unstructured":"LiuW. LiW.Effectiveness of reducing HIV transmission with an MMT program in Ruili China.Proceedings of the XIX International AIDS Conference Washington DC 25 July2012."},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina43030029"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000304704.71917.64"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000304695.54884.4f"},{"key":"e_1_2_6_105_1","unstructured":"TodadzeK. KavtiashviliE. ButsashviliT. KutateladzeT.Has life got better for HIV\u2010positive people on agonist maintenance treatment.Proceedings of the VI International AIDS Society on HIV Pathogenesis Treatment and Prevention Conference Geneva Switzerland 2011."},{"key":"e_1_2_6_106_1","unstructured":"Tran Thi ThanhH. Nguyen CuongQ. Nguyen Thi MinhT. Nguyen DucM. ThanhL. N. Nguyen ToN.et\u2009al.Effectiveness of the pilot program for the treatment of opioid dependence by methadone in Vietnam: results of a 24 month operational study.Proceedings of the XIX International AIDS Conference Washington DC 25 July2012."},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826089109062163"},{"key":"e_1_2_6_108_1","first-page":"947","article-title":"Methadone maintenance: results of treatment in heroin addict at Thanyarak Hospital (1990\u20131996)","volume":"81","author":"Verachai V.","year":"1998","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_6_109_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.649222"},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181c7dfb5"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12303","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.12303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T22:13:56Z","timestamp":1696371236000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.12303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/add.12303"],"URL":"https:\/\/doi.org\/10.1111\/add.12303","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]},"assertion":[{"value":"2013-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-07-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}